Central Garden & Pet Company (CENTA) Analysts See $0.08 EPS

November 10, 2018 - By Jimmy Baldridge

Central Garden & Pet Company (NASDAQ:CENTA) Logo

Analysts expect Central Garden & Pet Company (NASDAQ:CENTA) to report $0.08 EPS on November, 27.They anticipate $0.00 EPS change or 0.00 % from last quarter’s $0.08 EPS. CENTA’s profit would be $4.67M giving it 90.16 P/E if the $0.08 EPS is correct. After having $0.79 EPS previously, Central Garden & Pet Company’s analysts see -89.87 % EPS growth. The stock decreased 1.27% or $0.37 during the last trading session, reaching $28.85. About 147,494 shares traded. Central Garden & Pet Company (NASDAQ:CENTA) has risen 6.98% since November 11, 2017 and is uptrending. It has underperformed by 8.64% the S&P500.

Central Garden & Pet Company (NASDAQ:CENTA) Ratings Coverage

Among 2 analysts covering Central Garden \u0026 Pet (NASDAQ:CENTA), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Central Garden \u0026 Pet had 2 analyst reports since September 10, 2018 according to SRatingsIntel.

Central Garden & Pet Company, together with its subsidiaries, produces and markets products for the pet, and lawn and garden supplies industries in the United States. The company has market cap of $1.69 billion. It operates through two divisions, Pet and Garden. It has a 12.89 P/E ratio. The Pet segment supplies products for dogs and cats comprising edible bones, edible and non-edible chews, rawhide, dog and cat food and treats, toys, pet carriers, grooming supplies, and other accessories; and food, cages and habitats, toys, chews, and related accessories for birds, small animals, and specialty pets.

Another recent and important Central Garden & Pet Company (NASDAQ:CENTA) news was published by Nasdaq.com which published an article titled: “Detailed Research: Economic Perspectives on Cerus, AdvanSix, Spark Therapeutics, Imperva, Central Garden & Pet …” on October 18, 2018.

Central Garden & Pet Company (NASDAQ:CENTA) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: